Found: 23
Select item for more details and to access through your institution.
New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.
- Published in:
- Internal Medicine Journal, 2005, v. 35, n. 7, p. 419, doi. 10.1111/j.1445-5994.2005.00853.x
- By:
- Publication type:
- Article
Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.
- Published in:
- Scientific Reports, 2016, p. 29909, doi. 10.1038/srep29909
- By:
- Publication type:
- Article
Reply.
- Published in:
- Rheumatology, 2004, v. 43, n. 2, p. 251
- By:
- Publication type:
- Article
Churg–Strauss syndrome: the use of cyclophosphamide in mononeuritis.
- Published in:
- Rheumatology, 2003, v. 42, n. 2, p. 390, doi. 10.1093/rheumatology/keg067
- By:
- Publication type:
- Article
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
- Published in:
- Rheumatology, 2002, v. 41, n. 5, p. 558, doi. 10.1093/rheumatology/41.5.558
- By:
- Publication type:
- Article
Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.
- Published in:
- Rheumatology, 1999, v. 38, n. 1, p. 59, doi. 10.1093/rheumatology/38.1.59
- By:
- Publication type:
- Article
Asian ethnicity in systemic lupus erythematosus: an Australian perspective.
- Published in:
- Internal Medicine Journal, 2013, v. 43, n. 6, p. 618, doi. 10.1111/imj.12070
- By:
- Publication type:
- Article
Focus on systemic lupus erythematosus in Indigenous Australians: towards a better understanding of autoimmune diseases.
- Published in:
- Internal Medicine Journal, 2013, v. 43, n. 3, p. 227, doi. 10.1111/imj.12039
- By:
- Publication type:
- Article
Smooth muscle myopathy as an underrecognized manifestation of active systemic lupus erythematosus.
- Published in:
- Internal Medicine Journal, 2011, v. 41, n. 6, p. 495, doi. 10.1111/j.1445-5994.2011.02505.x
- By:
- Publication type:
- Article
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.
- Published in:
- Clinical & Experimental Immunology, 2001, v. 123, n. 2, p. 309, doi. 10.1046/j.1365-2249.2001.01423.x
- By:
- Publication type:
- Article
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis.
- Published in:
- Clinical & Experimental Immunology, 1997, v. 107, n. 2, p. 248, doi. 10.1111/j.1365-2249.1997.263-ce1154.x
- By:
- Publication type:
- Article
IDIOPATHIC POLYMYOSITIS COMPLICATED BY ARTHRITIS AND MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS: CASE REPORT AND REVIEW OF THE LITERATURE.
- Published in:
- British Journal of Rheumatology, 1993, v. 32, n. 10, p. 929
- By:
- Publication type:
- Article
GLUCOCORTICOIDS IN RHEUMATOID ARTHRITIS—MEDIATORS AND MECHANISMS.
- Published in:
- British Journal of Rheumatology, 1993, v. 32, n. 9, p. 816
- By:
- Publication type:
- Article
SCLEROTHERAPY AS TREATMENT OF RECURRENT BLEEDING FROM UPPER GASTROINTESTINAL TELANGIECTASIA IN CREST SYNDROME.
- Published in:
- British Journal of Rheumatology, 1993, v. 32, n. 8, p. 760
- By:
- Publication type:
- Article
Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin.
- Published in:
- Clinical & Experimental Immunology, 2011, v. 163, n. 2, p. 178, doi. 10.1111/j.1365-2249.2010.04289.x
- By:
- Publication type:
- Article
The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.
- Published in:
- Clinical & Experimental Immunology, 2008, v. 152, n. 2, p. 345, doi. 10.1111/j.1365-2249.2008.03629.x
- By:
- Publication type:
- Article
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.
- Published in:
- Clinical & Experimental Immunology, 2008, v. 152, n. 2, p. 372, doi. 10.1111/j.1365-2249.2008.03639.x
- By:
- Publication type:
- Article
Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
- Published in:
- Lupus, 2018, v. 27, n. 13, p. 2029, doi. 10.1177/0961203318804885
- By:
- Publication type:
- Article
Discordance of patient and physician health status concerns in systemic lupus erythematosus.
- Published in:
- Lupus, 2018, v. 27, n. 3, p. 501, doi. 10.1177/0961203317722412
- By:
- Publication type:
- Article
Validation of the Lupus Impact Tracker in an Australian patient cohort.
- Published in:
- Lupus, 2017, v. 26, n. 1, p. 98, doi. 10.1177/0961203316664593
- By:
- Publication type:
- Article
Glucocorticoid-Induced Leucine Zipper Governs the Therapeutic Potential of Mesenchymal Stem Cells by Inducing a Switch From Pathogenic to Regulatory Th17 Cells in a Mouse Model of Collagen-Induced Arthritis.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1514, doi. 10.1002/art.39069
- By:
- Publication type:
- Article
A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 17, p. 4087, doi. 10.1111/bph.12768
- By:
- Publication type:
- Article